Concepedia

Publication | Closed Access

Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

DOI

524

Citations

43

References

2006

Year

Ann Olincy, Josette G. Harris, Lynn Johnson, Vicki Pender, Susan Kongs, Diana Allensworth, Jamey Ellis, Gary O. Zerbe, Sherry Leonard, Karen E. Stevens,
Archives of General Psychiatry

Abstract

An alpha7 nicotinic agonist appears to have positive effects on neurocognition in persons with schizophrenia. Longer trials are needed to determine the clinical utility of this novel treatment strategy.

References

YearCitations

Page 1